1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55(1):10–0, 2005
2. Pazdur R., Coia LR, Wagman LD, Ayoub JP: Colorectal and Anal Cancers. In: Cancer Management: A Mulitidisciplinary Approach. Third Edition. Ed. By Pazdur R, Coia L, Hoskins WJ,Wagman LD. PRRR, Huntington NY, 1999
3. Tong WP, Hartshorn J, Mathews LA: Chloroquinoxaline sulfonamide, investigational drug brochure. National Cancer Institute, Division of Cancer treatment, 1987
4. Branda RF, McCormack JJ, Perlmutter CA: Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells. Biochem Pharmacol. 37(23):4557–564, 1988
5. Gao H, Yamasaki EF, Chan KK, Shen LL, Snapka RM: Chloroquinoxaline sulfonamide (NSC 339004) is a topoisomerase IIa/β poision. Cancer Res 60: 5937–940, 2000